Clinical Trials

Current COVID-19 Clinical Trials accepting patients: Clinical Trials List

CCP Study Collaboration
Sharp HealthCare Research is collaborating with Mayo Clinic on a study of expanded access to convalescent plasma for the treatment of patients with COVID-19. If CCP is new to you, learn more HERE.

If you are a physician looking to request plasma for your patient view the appropriate guidance below.
NOTE: Utilizing the Mayo approach ensures the data is tracked so treatment efficacy can be evaluated, but please use the eIND approach as needed.

Mayo Expanded Access	CCP Using eIND (FDA)
Guidance	Guidance
IRB Consent - English	Form 3926
IRB Consent - Spanish	IRB Consent - English
IRB Consent - Arabic	IRB Consent - Spanish

Know a patient who has recovered from COVID-19 and may be able to donate plasma? Share these instructions.